Pharmacological and clinical evaluation of deferasirox formulations for treatment tailoring

Abstract Deferasirox (DFX) is the newest among three different chelators available to treat iron overload in iron-loading anaemias, firstly released as Dispersible Tablets (DT) and more recently replaced by Film-Coated Tablets (FCT). In this retrospective observational study, pharmacokinetics, pharm...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Andrea Piolatto, Paola Berchialla, Sarah Allegra, Silvia De Francia, Giovanni Battista Ferrero, Antonio Piga, Filomena Longo
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Nature Portfolio 2021-06-01
Edice:	Scientific Reports
On-line přístup:	https://doi.org/10.1038/s41598-021-91983-w
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!